Clinical Integration definition

Clinical Integration shall have the meaning set forth in the 1996 Joint Statements of Antitrust Enforcement Policy in Health Care by the Federal Trade Commission and U.S.
Sample 1Sample 2Sample 3
Clinical Integration means a program of active and ongoing initiatives designed to evaluate and modify the practice patterns of, and create a high degree of interdependence and cooperation among, Network Providers, in order to improve the quality and efficiency of health care in the community, consistent with the relevant guidance and enforcement policies of the U.S. Department of Justice and the Federal Trade Commission.
Sample 1Sample 2Sample 3
Clinical Integration means a network of health 1-28 care providers implementing an active and ongoing program to 1-29 evaluate and modify practice patterns by the network ’s participants 1-30 and create a high degree of independence and cooperation to control 1-31 costs and ensure quality.
Sample 1

Examples of Clinical Integration in a sentence

  • IPQR Module 3.4 - Major Dependencies on Organizational Workstreams‌Instructions : Please describe any interdependencies with other organizational workstreams (IT Systems and Processes, Clinical Integration, etc.) Interdependencies with other work streams are as follows:1.

  • To obtain the additional benefit(s), the Member must complete the enhanced benefit application enrollment form and submit it to Us at: Anthem Dental Claims Attention: Clinical Integration CoordinatorP.O. Box 1115 Minneapolis, MN 55440-1115.

  • As required by a Payor Contract and to ensure the success of the HMHP’s Clinical Integration program to achieve quality and cost efficiencies in the delivery of Covered Services, Practice and the Participating Physicians shall refer Enrollees, when medically appropriate, only to other HMHP Providers.

  • At such time as HMHP implements its Clinical Integration program as a Clinically Integrated Network, HMHP may negotiate and enter into contracts with Payors that include all terms related to the delivery of Covered Services, including price and other terms related to payment (“CI Payor Contracts”).

  • Practice, therefore, agrees that it and its Participating Physicians shall cooperate in the development and implementation of HMHP’s Clinical Integration program.

  • IPQR Module 3.4 - Major Dependencies on Organizational Workstreams‌Instructions : Please describe any interdependencies with other organizational workstreams (IT Systems and Processes, Clinical Integration, etc.) Financial Sustainability is in many ways the "end game" of the DSRIP transformation effort and, as such, has a critical interdependency with all operational and clinical performance workstreams.

  • A positive atmosphere of professionalism and collegiality is essential for everyone to perform to the best of his or her abilities.

  • The BAHN is in the process of negotiating and executing a final contractual agreement, with an effective date of January 1, 2013 for participation in the Pioneer ACO with North Shore-LIJ Clinical Integration Network IPA (CIIPA) under which CMO will provide care management services, disease management services, and quality management services for Medicare beneficiaries assigned to the BAHN under the Participating Agreement with CIIPA.

  • Practice and the Participating Physicians understand that Clinical Integration and the success of HMHP as a Clinically Integrated Network require Practice’s and the Participating Physicians’ active and ongoing participation.

  • Students will be required to meet with the Associate/Assistant Dean of Clinical Education and Associate Dean of Clinical Integration and Assessment to develop a study plan.


More Definitions of Clinical Integration

Clinical Integration means a health system that has demonstrated clinical leadership by taking accountability for delivering integrated clinical care delivery models for a defined population that are designed to produce quality, cost, efficiency and value.
Sample 1Sample 2
Clinical Integration means a showing by the health care
Sample 1
Clinical Integration means a network of health 3-32 care providers implementing an active and ongoing program to 3-33 evaluate and modify practice patterns by the network ’s participants 3-34 and create a high degree of independence and cooperation to control 3-35 costs and ensure quality.
Sample 1
Clinical Integration means a collaborative effort among providers and a central organizing system to implement clinical initiatives that control costs and improve quality, typically by strengthening coordination, standardizing clinical processes and protocols, and investing significantly in a centralized infrastructure.7
Sample 1Sample 2
Clinical Integration means a program of active and ongoing initiatives designed to evaluate and modify the practice patterns of, and create a high degree of interdependence and cooperation among physicians affiliated with the Member, in order to improve the quality and efficiency of health care in the community, and may change in meaning as that term may be subsequently defined by relevant guidance and enforcement policy of the U.S. Department of Justice and the Federal Trade Commission.
Sample 1

Related to Clinical Integration

  • clinical investigation means any systematic investigation in one or more human subjects, undertaken to assess the safety or performance of a device;

  • Bioassay means the determination of kinds, quantities or concentrations and, in some cases, the locations of radioactive material in the human body, whether by direct measurement, in vivo counting, or by analysis and evaluation of materials excreted or removed from the human body. For purposes of these rules, “radiobioassay” is an equivalent term.

  • Commercialization or “Commercialize” means activities directed to marketing, promoting, research and development as required, manufacturing for sale, offering for sale, distributing, importing or selling a product, including sub-licensing or sub-contracting of these activities.

  • Research Use shall have the meaning given in Section 2.2.2 of this Agreement.

  • Phase 4 Clinical Trial means a Clinical Study in any country which is conducted after Regulatory Approval of a product has been obtained from an appropriate Regulatory Authority, consisting of trials conducted voluntarily for enhancing marketing or scientific knowledge of an approved indication and trials conducted due to request or requirement of a Regulatory Authority.

  • Analytical x-ray system means a group of components utilizing x-rays to determine the elemental composition or to examine the microstructure of materials.

  • Pre-Licensed Therapist means an individual who has obtained a Master’s Degree in Social Work or Marriage and Family Therapy and is registered with the BBS as an Associate CSW or MFT Intern acquiring hours for licensing. An individual’s registration is subject to regulations adopted by the BBS.

  • Software Product means any COTS which you propose to provide pursuant to the contract.

  • Manufacturing Technology means any and all patents, patent applications, Know-How, and all intellectual property rights associated therewith, and including all tangible embodiments thereof, that are necessary or useful for the manufacture of adeno- associated viruses, adeno-associated virus vectors, research or commercial reagents related thereto, Licensed Products, or other products, including manufacturing processes, technical information relating to the methods of manufacture, protocols, standard operating procedures, batch records, assays, formulations, quality control data, specifications, scale up, any and all improvements, modifications, and changes thereto, and any and all activities associated with such manufacture. Any and all chemistry, manufacturing, and controls (CMC), drug master files (DMFs), or similar materials provided to regulatory authorities and the information contained therein are deemed Manufacturing Technology.

  • Clinical Study means a Phase I Study, Phase II Study, Phase III Study, as applicable.

  • Manufacturing Know-How means, with respect to the Product or any Variant thereof, the technology, data, designs, processes, methods, specifications and other know-how used in connection with the formulation, manufacture, labeling, packaging, quality control, release testing, and production of the Product, and all ingredients used therein and portions thereof.

  • Clinical means having a significant relationship, whether real or potential, direct or indirect, to the actual rendering or outcome of dental care, the practice of dentistry, or the quality of dental care being rendered to a patient;

  • Biomarker means a parameter or characteristic in a patient or Patient Sample, the measurement of which is useful (a) for purposes of selecting appropriate therapies or patient populations or monitoring disease susceptibility, severity or state, or monitoring therapies for such patient and/or (b) for predicting the outcome of a particular treatment of such patient.

  • Clinical Trials means a controlled study in humans of the safety or efficacy of a Product, and includes, without limitation, such clinical trials as are designed to support expanded labeling or to satisfy the requirements of an Agency in connection with any Product Approval and any other human study used in research and Development of a Product.

  • Collaboration Know-How means all Know-How conceived, discovered, developed or otherwise made by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing (solely or jointly by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing) in the course of [***].

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.

  • Clinical Trial means a Phase I Clinical Trial, Phase II Clinical Trial or Phase III Clinical Trial, or any post-approval human clinical trial, as applicable.

  • Assistive technology device means any item, piece of equipment, or product system that is used to increase, maintain, or improve the functional capacities of a child with a disability.

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • Clinical Studies means Xxxxx 0, Xxxxx 0, Xxxxx 0, Xxxxx 3, and such other tests and studies in human subjects that are required by Applicable Law, or otherwise recommended by the Regulatory Authorities, to obtain or maintain Regulatory Approvals for a Licensed Product for one (1) or more indications, including tests or studies that are intended to expand the Product Labeling for such Licensed Product with respect to such indication.

  • in vitro diagnostic medical device means any medical device which is a reagent, reagent product, calibrator, control material, kit, instrument, apparatus, equipment, software or system, whether used alone or in combination, intended by the manufacturer to be used in vitro for the examination of specimens, including blood and tissue donations, derived from the human body, solely or principally for the purpose of providing information:

  • Licensed Compounds means any EZH2 Compound(s) that is:

  • Investigational Medicinal Product means the study drug or control material as defined in the Protocol.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Companion Diagnostic means a device which is essential for the safe and effective use of a corresponding medicinal product to:

  • SDK means the JetBrains Rider Software Development Kit and specifically including any associated JetBrains Rider software files, documentation, software code or other materials made available by JetBrains and any third-party software programs that are owned and licensed by parties other than JetBrains and that are either integrated with or made part of the SDK (collectively, “Third-Party Software”).